Avior Wealth Management’s Guardant Health GH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$816K Buy
5,436
+1,177
+28% +$128K 0.02% 410
2026
Q1
$393K Buy
+4,259
New +$428K 0.01% 600
2025
Q1
Sell
-1,100
Closed -$33.6K 1369
2024
Q4
$33.6K Hold
1,100
﹤0.01% 1276
2024
Q3
$25.2K Sell
1,100
-2,310
-68% -$65.4K ﹤0.01% 1325
2024
Q2
$98.5K Buy
3,410
+3,383
+12,530% +$78.8K ﹤0.01% 866
2024
Q1
$557 Buy
+27
New +$579 ﹤0.01% 2543
2022
Q4
Sell
-4,907
Closed -$264K 1303
2022
Q3
$264K Buy
4,907
+105
+2% +$5.39K 0.02% 405
2022
Q2
$193K Buy
4,802
+3,448
+255% +$171K 0.02% 423
2022
Q1
$89K Buy
+1,354
New +$92.7K 0.01% 528

Other funds holding GH

Avior Wealth Management's GH Position: Q2 2026 in Review

Avior Wealth Management increased its Guardant Health (GH) stake by 28% in Q2 2026, buying an estimated $128K and bringing the position to 5,436 shares worth $816K. The position accounts for 0.02% of the portfolio, ranked #410.

Avior Wealth Management first reported a position in GH in Q1 2022 and has held it in 9 quarters since. 47 funds tracked by Wall St. Rank hold GH as of Q2 2026.

  • Avior Wealth Management held 5,436 shares of Guardant Health worth $816K as of Q2 2026.
  • Avior Wealth Management bought 1,177 Guardant Health shares in Q2 2026, an estimated $128K.
  • Guardant Health made up 0.02% of Avior Wealth Management's portfolio in Q2 2026, its #410 holding.
  • Avior Wealth Management first reported a position in Guardant Health in Q1 2022 and has held it in 9 quarters since.
  • 47 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.

Based on Avior Wealth Management's 13F filing for Q2 2026, filed 7 Jul 2026.